mBioWorks ApS: Financial statements 2024
CVR: 43186957
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
mBioWorks ApS (CVR 43186957) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -78,973 and a net result of DKK -122,969 compared with DKK 24,537 the year before. Equity in the 2024 report amounted to DKK 239,564. The solvency ratio was 70.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -78,973
- Profit/Loss
- DKK -122,969
- Equity
- DKK 239,564
- Total Assets
- DKK 339,657
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -79 t. | -123 t. | 240 t. | 1 |
| 2023 | 58 t. | 58 t. | 25 t. | 355 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
MBioWorks ApS has published its annual report for 2023. Revenue came to DKK 57,949, and the net result was DKK 24,537.
About mBioWorks ApS
mBioWorks ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Yonghui Zeng. The company is owned by Yonghui Zeng. According to the 2025 annual report, the company had an average of 4 employees. In 2025, the company reported a gross profit of DKK 76,775 and a net result of DKK 17,506 compared with DKK -122,969 the year before. Equity in the 2025 report amounted to DKK 256,690.